PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50325C00020Rafa atropine auto-injectors (0.5 MG 1 — Rafa Laboratories Ltd

Rafa Laboratories Ltd holds $54.5M across 3 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Aspr/Orm-Sns

Awarding office

Rafa Laboratories Ltd

Recipient

Sep 29, 2027

PoP end

$33.4M

Obligated

$46.2M

Potential

325412

NAICS

6505

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number75A50325C00020

AgencyAspr/Orm-Sns

Awarding officeAspr/Orm-Sns

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentRafa Laboratories Ltd

CAGE0905A

UEICKDNTKNDPMJ6

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startSep 30, 2025

PoP end (current)Sep 29, 2027

PoP end (w/ options)Sep 29, 2028

Obligated$33.4M

Current value$33.4M

Potential value$46.2M

Rafa Atropine Auto-Injectors (0.5 MG, 1 MG, AND 2 MG) is a federal Unrestricted award for Aspr/Orm-Sns held by Rafa Laboratories Ltd. Estimated value $46.2M ($33.4M obligated). Current period of performance ends Sep 29, 2027 (potential Sep 29, 2028). Last award drew 1 bidder.

Rafa atropine auto-injectors (0.5 mg, 1 mg, and 2 mg). Latest action is a modification.

Recompete timing

Public

● Expiring in 341 days

Current PoP ends Sep 29, 2027 (341 days remaining). Agencies typically plan 12–18 months ahead — at 11.2 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 75A50325C00020? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Rafa Laboratories Ltd — $54.5M obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$54.5M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50325C00020?

75A50325C00020 (Rafa atropine auto-injectors (0.5 MG 1) is a Aspr/Orm-Sns award with a potential value of $46.2M, currently held by Rafa Laboratories Ltd. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50325C00020?

Aspr/Orm-Sns awarded 75A50325C00020 to Rafa Laboratories Ltd (potential $46.2M).

Who is the incumbent on 75A50325C00020?

Rafa Laboratories Ltd is the incumbent with $54.5M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does Rafa Laboratories Ltd’s 75A50325C00020 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50325C00020? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jul 29, 2026